scholarly journals A cell cycle arrest is necessary for bottle cell formation in the early Xenopus gastrula: Integrating cell shape change, local mitotic control and mesodermal patterning

2005 ◽  
Vol 122 (12) ◽  
pp. 1251-1265 ◽  
Author(s):  
Thomas Kurth
Keyword(s):  
Cell Cycle ◽  
Cell Cycle Arrest ◽  
Cell Shape ◽  
Shape Change ◽  
Cell Formation ◽  
Cell Shape Change ◽  
Cycle Arrest ◽  
Mitotic Control ◽  
A Cell

scholarly journals Proteotoxic Stress Induces a Cell-Cycle Arrest by Stimulating Lon to Degrade the Replication Initiator DnaA

Cell ◽  
2013 ◽  
Vol 154 (3) ◽  
pp. 623-636 ◽  
Author(s):  
Kristina Jonas ◽  
Jing Liu ◽  
Peter Chien ◽  
Michael T. Laub
Keyword(s):  
Cell Cycle ◽  
Cell Cycle Arrest ◽  
Proteotoxic Stress ◽  
Cycle Arrest ◽  
A Cell ◽  
Replication Initiator

scholarly journals Triggering a Cell Shape Change by Exploiting Preexisting Actomyosin Contractions

Science ◽  
2012 ◽  
Vol 335 (6073) ◽  
pp. 1232-1235 ◽  
Author(s):  
Minna Roh-Johnson ◽  
Gidi Shemer ◽  
Christopher D. Higgins ◽  
Joseph H. McClellan ◽  
Adam D. Werts ◽  
...  
Keyword(s):  
Cell Shape ◽  
Shape Change ◽  
Cell Shape Change ◽  
A Cell

Exploratory analysis of the effect of taselisib on downstream pathway modulation and correlation with tumor response in ER-positive/HER2-negative early-stage breast cancer from the LORELEI trial.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. 1050-1050 ◽  
Author(s):  
Paolo Nuciforo ◽  
Dominik Hlauschek ◽  
Cristina Saura ◽  
Evandro de Azambuja ◽  
Roberta Fasani ◽  
...  
Keyword(s):  
Cell Cycle ◽  
Cell Cycle Arrest ◽  
Early Stage ◽  
Objective Response ◽  
Wild Type ◽  
Cycle Arrest ◽  
Er Positive ◽  
A Cell ◽  
Tumor Biopsies ◽  
Clinical Trial Information

1050 Background: Taselisib (T) is an oral, potent, selective inhibitor of Class I PI3-kinase with enhanced activity against PIK3CA mutant cancer cells. Results from the LORELEI trial have demonstrated a significant improvement in ORR (objective response rate) by centrally assessed magnetic resonance imaging in all randomized patients as well as in the PIK3CA mutant (MT) cohort treated with neoadjuvant T plus letrozole (L) compared to placebo (P) plus L. Here we present the results of exploratory analyses of selected pathway-related phosphoproteins. Methods: Baseline (BL) and week3 (W3) tumor biopsies were obtained from 334 patients enrolled in the trial. Phosphoproteins (pAKT, pPRAS40 and pS6) were analyzed by IHC. BL levels as well as changes from BL to W3 were correlated with response assessed either by ORR or cell cycle arrest (Ki67 at W3 < 2.7%). Results: In the overall population, BL phosphoproteins levels were similar between the T and P arms. Higher pAKT (p < 0.001) and pPRAS40 (p = 0.004) levels were observed in MT vs wild-type (WT), whereas the opposite result was found for pS6 (p = 0.03). Treatment-induced absolute changes of phosphoproteins adjusted for BL levels were not significantly different between the T and P arms in the overall population, except for pPRAS40 with higher decrease in the T arm (p = 0.014). After stratification for PIK3CA genotype, a significantly greater decrease in expression levels was observed for pPRAS40 (p < 0.001) and pS6 (p = 0.020) in MT tumors treated with T. The treatment effects were not significantly different in the WT population. A trend for an association between decrease in pS6 levels at W3 and improved ORR was observed in the MT (p = 0.08) and T (p = 0.09) subgroups. The magnitude of pS6 suppression at W3 was higher in tumors achieving a cell cycle arrest in the MT/T subgroup (biserial correlation = -0.473). Conclusions: Exploratory analyses of phosphoproteins showed bioactivity of taselisib as indicated by downstream pathway suppression. Translational research aiming to integrate these results with additional exploratory biomarkers data is currently ongoing. Clinical trial information: NCT02273973.

scholarly journals Mitochondrial DNA Damage Initiates a Cell Cycle Arrest by a Chk2-associated Mechanism in Mammalian Cells

2009 ◽  
Vol 284 (52) ◽  
pp. 36191-36201 ◽  
Author(s):  
Christopher A. Koczor ◽  
Inna N. Shokolenko ◽  
Amy K. Boyd ◽  
Shawn P. Balk ◽  
Glenn L. Wilson ◽  
...  
Keyword(s):  
Cell Cycle ◽  
Dna Damage ◽  
Mitochondrial Dna ◽  
Cell Cycle Arrest ◽  
Mammalian Cells ◽  
Mitochondrial Dna Damage ◽  
Cycle Arrest ◽  
A Cell

scholarly journals Dynamic myosin phosphorylation regulates contractile pulses and tissue integrity during epithelial morphogenesis

2014 ◽  
Vol 206 (3) ◽  
pp. 435-450 ◽  
Author(s):  
Claudia G. Vasquez ◽  
Mike Tworoger ◽  
Adam C. Martin
Keyword(s):  
Cell Shape ◽  
Shape Change ◽  
Epithelial Morphogenesis ◽  
Nonmuscle Myosin ◽  
Apical Constriction ◽  
Tissue Integrity ◽  
Cell Shape Change ◽  
Nonmuscle Myosin Ii ◽  
A Cell ◽  
Coupling Dynamic

Apical constriction is a cell shape change that promotes epithelial bending. Activation of nonmuscle myosin II (Myo-II) by kinases such as Rho-associated kinase (Rok) is important to generate contractile force during apical constriction. Cycles of Myo-II assembly and disassembly, or pulses, are associated with apical constriction during Drosophila melanogaster gastrulation. It is not understood whether Myo-II phosphoregulation organizes contractile pulses or whether pulses are important for tissue morphogenesis. Here, we show that Myo-II pulses are associated with pulses of apical Rok. Mutants that mimic Myo-II light chain phosphorylation or depletion of myosin phosphatase inhibit Myo-II contractile pulses, disrupting both actomyosin coalescence into apical foci and cycles of Myo-II assembly/disassembly. Thus, coupling dynamic Myo-II phosphorylation to upstream signals organizes contractile Myo-II pulses in both space and time. Mutants that mimic Myo-II phosphorylation undergo continuous, rather than incremental, apical constriction. These mutants fail to maintain intercellular actomyosin network connections during tissue invagination, suggesting that Myo-II pulses are required for tissue integrity during morphogenesis.

scholarly journals Telomeres come up short in heart regeneration

2016 ◽  
Vol 213 (5) ◽  
pp. 497-497
Author(s):  
Ben Short
Keyword(s):  
Cell Cycle ◽  
Cell Cycle Arrest ◽  
Heart Regeneration ◽  
Cycle Arrest ◽  
A Cell

Cardiomyocyte telomeres erode after birth, inducing a cell-cycle arrest that limits the heart’s capacity for regeneration.

scholarly journals Agmatine inhibits growth via a cell cycle arrest and confers resistance to apoptosis

2008 ◽  
Vol 22 (S1) ◽  
Author(s):  
Mary Ann Arndt ◽  
Eva Parisi ◽  
Masato Isome ◽  
Joseph Satriano
Keyword(s):  
Cell Cycle ◽  
Cell Cycle Arrest ◽  
Cycle Arrest ◽  
A Cell
Sign in / Sign up

Export Citation Format

Share Document